Amitraz
Cat.No:IA3310 Solarbio
CAS:33089-61-1
Molecular Formula:C19H23N3
Molecular Weight:293.41
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Endocrinology & Hormones >
AmitrazCAS:33089-61-1
Molecular Formula:C19H23N3
Molecular Weight:293.41
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
CAS | 33089-61-1 |
Name | Amitraz |
Molecular Formula | C19H23N3 |
Molecular Weight | 293.41 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 251-375-4 |
MDL | MFCD00069396 |
SMILES | CN(/C=N/C1=CC=C(C)C=C1C)/C=N/C2=CC=C(C)C=C2C |
InChIKey | QXAITBQSYVNQDR-UHFFFAOYSA-N |
InChI | InChI=1S/C19H23N3/c1-14-6-8-18(16(3)10-14)20-12-22(5)13-21-19-9-7-15(2)11-17(19)4/h6-13H,1-5H3 |
PubChem CID | 36324 |
Target Point | Adrenergic Receptor |
Passage | Endocrinology & Hormones;GPCR & G Protein;Neuronal Signaling |
Background | Amitraz has alpha-adrenergic agonist activity. |
Biological Activity | Amitraz (NSC 324552) 是一种α2 肾上腺素能受体激动剂。它是非系统性杀螨剂和杀虫剂。[1-2] |
Data Literature Source | [1] Young FM,et al. Hum Reprod. 2005,20(11):3018-25. [2] Moser VC,et al. Fundam Appl Toxicol. 1989,12(1):12-22. |
Unit | Bottle |
Specification | 25mg 50mg 100mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.